Presentation is loading. Please wait.

Presentation is loading. Please wait.

V. Yilmaz 1, P. Oflazer 2, F. Aysal 3, Y.G. Parman 2, H. Direskeneli 4, F. Deymeer 2, G. Saruhan-Direskeneli 1 I.U. Istanbul Medical Faculty Departments.

Similar presentations


Presentation on theme: "V. Yilmaz 1, P. Oflazer 2, F. Aysal 3, Y.G. Parman 2, H. Direskeneli 4, F. Deymeer 2, G. Saruhan-Direskeneli 1 I.U. Istanbul Medical Faculty Departments."— Presentation transcript:

1 V. Yilmaz 1, P. Oflazer 2, F. Aysal 3, Y.G. Parman 2, H. Direskeneli 4, F. Deymeer 2, G. Saruhan-Direskeneli 1 I.U. Istanbul Medical Faculty Departments of Physiology and Neurology, (3) Bakirkoy Hospital (4) Marmara University, Faculty of Medicine, Division of Rheumatology, Istanbul/Turkey

2 Neuromuscular junction Vincent A,

3 Auto-antibodies in MG Anti-AChR antibody (AP) 85-90 % IgG1-2a (Complement activated) Seronegative MG 15-10% Anti-AChR (-) Anti-MuSK (-) (SN) 56% 5-8% Anti-MuSK (Muscle specific kinase) (MP) 44% 4-6% IgG4 and IgG1 (Complement activity?)

4 b |Complement C9 deposition in MG NT: nerve terminal PSF: postsynaptic folds Role of the complement activation in anti- AChR (+) MG

5 Role of Cytokines in Regulation of Antibody Production T cell help CD40L (Ligand) interaction Cytokine

6 Basal Cytokine Secretion of PBMC in MG IFN  IL-13 IL-10 N 59 22 MG CON * p< 0.001 N 59 22 MG CON N 59 22 MG CON PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC)

7 CD3 Stimulation of MG PBMC IFN  IL-13 IL-10 N 25 16 18 SN MP AP * p=0.001 * p<0.001 N 25 16 18 SN MP AP N 25 16 18 SN MP AP

8 Study Group N ♂♀ Mean age Immunosuppres sive treatment MG75502543.133 AP37152242.711 MP1541139.712 SN236174610 Rheumatoid Arthritis (RA) 2361753.211 Controls3216 40.6

9 B Cells in the Periphery SUBGROUPS of MG % of CD19+CD27+

10 BAFF RECEPTOR (BAFFR) in MG p: 0.001p: 0.006 SUBGROUPS of MG

11 T Helper Cells (Th2): CD4+CCR4+ p: 0.04 p: 0.015

12 T cell help CD40L (Ligand) interaction Cytokine Role of Cytokines in Regulation of Antibody Production

13 T Cell Help: CD40L expression in isolated CD4+ T cells BOTH MG and CON were higher than RA CON

14 NO TREATMENT MP> RA SN>RA T Cell Help: CD40L expression in CD4+ T cells

15 T Cell Help: IL-10 and IFN-  expression in isolated CD4+ T cells CON

16 IL-10 and IL-6 expression in isolated CD19+ B cells CON

17 B cell activation B cell receptor (BCR = Ig)Specific antigenAChR/MuSK ImmunoglobulinPoly Ig T cell helpCD40- CD40L B cell co-receptors TLRTLR-9CpG/non-CpG

18 TLR Stimulation of B Cells

19 Regulatory Role of B Cells by IL-10 Secretion

20 IL-10 Response to Nonspecific Stimuli Basal Poly Ig CpG Basal: SN<CON* MP<CON* RA<CON* AP<CON Poly Ig: SN<CON* RA<CON* MP<CON AP<CON

21 Basal tAChR rMuSK IL-10 production of B cells in response to specific antigens AChR: MP<CON* RA<CON* SN<CON AP<CON No subgroup related antigen specific responses

22 IL-6 Response to Non-specific Stimuli Basal Poly Ig CpG Basal: MP<CON* RA<CON* AP<CON SN<CON Poly Ig: MP<CON* AP<CON* RA<CON* SN<CON

23 AChR MP < CON* RA < CON* IL-6 Response to Specific Stimuli No subgroup related antigen specific responses

24 TNF-  Response to Stimulation Basal Poly Ig CpG Poly Ig: MP<CON* SN<CON* No differences in responses to AChR and MuSK between groups

25 TNF-  Response to Non-specific Stimuli Basal Poly Ig CpG Basal: MP<CON* AP<CON* RA<CON* Poly Ig: MP<CON* SN>CON

26 TNF-  Response to Specific Stimuli AChR: RA<CON* Basal tAChR rMuSK No subgroup related antigen specific responses

27 IL-12p40 Secretion in Response to Non-specific Stimulation No differences in responses to AChR and MuSK between groups AP MP SN RA CON

28 CONCLUSION B cell related or B cell derived cytokine activity in antibody- based subgroups of MG did not reveal a specific pattern for disease development The differences between RA and MG point to differential cytokine effects in these diseases Untreated patients in all subgroups are needed to clairify the differential features in this disease.

29

30 PLASMA vs. CULTURE SUPERNATANTS Only RA higher than MG and controls IL-10 Lower in AP compared to RA and Controls IL-13 Higher in RA only

31

32 mRNA expression in CD19+ B cells

33 IL-6 Response to Specific Stimuli in Non-treated Patients

34 IL-6 Response to Non-specific Stimuli in Non- treated Patients Basal Poly Ig CpG

35 IL-6 production of B cells in response to specific antigens

36 TNF-  Response to Non-specific Stimuli in Un- treated Patients

37 TNFB-

38 TNFA Antigen-Specific Stimulation

39 IL-10 Response to Nonspecific Stimuli in unteated MG SN<CON <RA


Download ppt "V. Yilmaz 1, P. Oflazer 2, F. Aysal 3, Y.G. Parman 2, H. Direskeneli 4, F. Deymeer 2, G. Saruhan-Direskeneli 1 I.U. Istanbul Medical Faculty Departments."

Similar presentations


Ads by Google